Condition
Surfactant Dysfunction
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03822780Not ApplicableCompletedPrimary
Hydroxychloroquin (HCQ) in chILD of Genetic Defect
NCT04532346Early Phase 1Recruiting
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
NCT04777760Recruiting
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
NCT05002478Not ApplicableRecruiting
Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial
NCT06090981Not ApplicableCompleted
Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome
Showing all 5 trials